Article Excerpt: Millions of people worldwide are affected by alcohol use disorder, a debilitating addiction that can disrupt daily life and overall health. Alcohol use disorder is characterized by an inability to control drinking, a preoccupation with alcohol and continued use despite negative consequences.
According to the World Health Organization, 400 million people, or 7% of the world’s population ages 15 and older, had an alcohol use disorder in 2019. Yet the primary prescribed medications, such as acamprosate, are only beneficial for a subset of patients.
To improve these outcomes, scientists at Mayo Clinic’s Center for Individualized Medicine are pioneering the use of advanced research technologies to peel back the layers of this complex condition and understand the varying responses to treatments. Their goal is to develop personalized therapy strategies that are precisely tailored to each patient’s genomic profile.
Full Article: https://tinyurl.com/98pd3vak
Article Source: Mayo Clinic News Network